These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11788628)

  • 1. Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients.
    Mericq V; Gajardo H; Eggers M; Avila A; Cassorla F
    J Clin Endocrinol Metab; 2002 Jan; 87(1):84-9. PubMed ID: 11788628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
    Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
    J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of luteinizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: preliminary results.
    Cassorla F; Mericq V; Eggers M; Avila A; García C; Fuentes A; Rose SR; Cutler GB
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3989-92. PubMed ID: 9398701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study.
    Shalet SM; Shavrikova E; Cromer M; Child CJ; Keller E; Zapletalová J; Moshang T; Blum WF; Chipman JJ; Quigley CA; Attanasio AF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4124-9. PubMed ID: 12970274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
    Saggese G; Federico G; Barsanti S; Fiore L
    J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.
    Theintz G; Buchs B; Rizzoli R; Slosman D; Clavien H; Sizonenko PC; Bonjour JP
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1060-5. PubMed ID: 1400871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence.
    Bonjour JP; Theintz G; Buchs B; Slosman D; Rizzoli R
    J Clin Endocrinol Metab; 1991 Sep; 73(3):555-63. PubMed ID: 1874933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.
    de Lind van Wijngaarden RF; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; van Leeuwen M; Haring DA; Bocca G; Mieke Houdijk EC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3763-71. PubMed ID: 19622627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Katsumata N; Tachibana K; Nose O; Hibi I
    Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone.
    Balducci R; Toscano V; Mangiantini A; Municchi G; Vaccaro F; Picone S; Di Rito A; Boscherini B
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3596-600. PubMed ID: 8530605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
    Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
    J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.